GP
ELOS

GLG Partners’s Syneron Medical Ltd ELOS Stock Holding History

GLG Partners’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-143,548
Closed -$1.57M – 410
2017
Q2 		$1.57M Buy
+143,548
New +$1.57M 0.09% 219

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

GLG Partners's ELOS Position: Q3 2017 in Review

GLG Partners sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 143,548 shares — an estimated $1.57M sold.

GLG Partners first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $1.57M in Q2 2017. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • GLG Partners reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • GLG Partners sold 143,548 Syneron Medical Ltd shares in Q3 2017, an estimated $1.57M.
  • GLG Partners first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • GLG Partners's Syneron Medical Ltd position peaked at $1.57M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on GLG Partners's 13F filing for Q3 2017, filed 14 Nov 2017.